Natural killer T (NKT)^1^ cells represent a novel lymphoid lineage distinct from mainstream T cells, B cells, and NK cells. NKT cells are characterized by the expression of an invariant TCR encoded by Vα14 and Jα281 gene segments and Vβ8, 7, or 2 gene segments ([@B1], [@B2]). It was demonstrated recently that NKT cells are strongly stimulated by the glycolipid α-galactosylceramide (α-GalCer), a potent inducer of antitumor immunity in mice ([@B3]--[@B5]). Recognition of α-GalCer by NKT cells appeared to depend on the interaction of the invariant TCR of these cells with α-GalCer presented by the nonclassical MHC molecule CD1d on APCs ([@B6]). Stimulation of NKT cells by α-GalCer resulted in the production of large amounts of IFN-γ and some IL-4, and the development of a cytotoxic phenotype ([@B7]).

The in vivo antitumor activity of α-GalCer strongly resembles the antitumor activity mediated by the cytokine IL-12 ([@B8], [@B9]). Moreover, both α-GalCer and IL-12 are strong inducers of NKT cell activity and exert their antitumor activities through activation of these cells ([@B8], [@B9]). Because of these striking similarities between α-GalCer and IL-12 for activation of NKT cells, we decided to investigate whether α-GalCer activation of NKT cells involves regulation by IL-12. First, we demonstrated that NKT cells are the main, if not the only, target for activation by α-GalCer in spleen cell populations of mice. Second, we showed that endogenous IL-12 produced by dendritic cells (DCs) is critically important for the activation of NKT cells by α-GalCer and that the interaction between DCs and NKT cells involves CD40 and its ligand. Third, α-GalCer induced the expression of IL-12R on NKT cells, which required the production of IFN-γ by NKT cells. Fourth, α-GalCer acted synergistically with IL-12 in the activation of natural killing activity and IFN-γ production in vivo. Collectively, these findings indicate that α-GalCer exerts its function through IL-12 and suggest a novel approach for therapeutic intervention in cancer and other disease processes.

Materials and Methods
=====================

Mice.
-----

C57BL/6 mice were purchased from Charles River Japan. Vα14 NKT cell--deficient (Jα281^−/−^) and CD1d^−/−^ mice were established by specific deletion of the Jα281 and CD1d gene segment, respectively ([@B3], [@B10]). All mice used in this study were at 5--8 wk of age and were maintained in specific pathogen-- free conditions.

α-GalCer.
---------

α-GalCer \[(2S,3S,4R)-1-*O*-(α-[d]{.smallcaps}-galactopyranosyl)-2-(*N*-hexacosanoylamino)-1,3,4-octadecanetriol\] used for this study was provided by Dr. Y. Koezuka (Kirin Brewery Co., Ltd., Gunma, Japan \[4, 5\]). The stock solution of α-GalCer (220 μg/ml) was diluted in 0.5% polysorbate 20 (Nikko Chemical) in 0.9% NaCl solution. This stock solution was further diluted into an appropriate concentration with saline and used for the experiments. A vehicle control solution was prepared from a solution of 0.5% polysorbate 20 in 0.9% NaCl solution. The vehicle control was used in all experiments.

Isolation of Lymphoid Cell Subsets by FACS^®^.
----------------------------------------------

Spleen cells were incubated on nylon wool columns for 45 min, and the nonadherent cells were used for the isolation of NKT cells, NK cells, CD4^+^ T cells, and CD8^+^ T cells by cell sorting using a FACS Vantage™ instrument (Becton Dickinson). All mAbs used in these experiments (mAbs against NK1.1, CD4, CD8, and TCR-α/β) were purchased from PharMingen. Unless noted otherwise, NK1.1^+^TCR-α/β^+^ cells were used as purified NKT cells. The stained cells were isolated using the FACS Vantage™. The purity of the sorted cells was \>98%. The details of the staining and sorting have been described previously ([@B11]).

Coculture of DCs and NKT Cells.
-------------------------------

DCs were prepared according to the method of Steinman et al. ([@B12]) with some modifications. In brief, spleen cells were incubated in 10-cm plastic dishes (Falcon; Becton Dickinson) for 2 h, and the nonadherent cells were removed from the culture. The adherent cells were further incubated overnight and the nonadherent cells were harvested. Then, CD11c^+^B220^−^CD4^−^CD8^−^ cells were isolated from the nonadherent populations by cell sorting and used as the source of DCs. Generally, DCs (10^5^) were cocultured with purified NK1.1^+^TCR-α/β^+^ NKT cells (2 × 10^5^) in the presence of 50 ng/ml of α-GalCer in 96-well U-bottomed plates (Costar Corp.). After incubation for 36 h, the culture supernatants were harvested to detect cytokine levels.

Detection of Cytokine Activity.
-------------------------------

IL-4 or IFN-γ activity in culture supernatants was determined using the Biotrac™ mouse IL-4 or Biotrac™ mouse IFN-γ ELISA system (Nycomed Amersham plc). Serum samples were obtained from C57BL/6 mice 24 h after injection of α-GalCer (200 ng/mouse) and/or IL-12 (200 U/mouse; donated by Genetics Institute, Inc., Cambridge, MA), and cytokine levels were measured using ELISA kits (Nycomed Amersham plc). IL-12 p70 activity in culture supernatants was measured using Intertest-12X™ ELISA kits (Genzyme Corp.).

Cytotoxicity Assay.
-------------------

The natural killing activity of spleen cells was determined by 4-h ^51^Cr-release assays using YAC-1 cells as target. 1 lytic unit (LU) was defined as the number of effector cells required to cause 25% lysis of 2,500 target cells as described previously ([@B13]).

Measurement of the Synergistic Effect of α-GalCer and IL-12 In Vivo.
--------------------------------------------------------------------

Wild-type C57BL/6 mice received an injection of α-GalCer (200 ng/mouse i.v.), and 6 h later mice were injected with recombinant IL-12 (200 U/mouse i.p.) or saline. 1 d after treatment with IL-12, IFN-γ production in the serum and NK activity of spleen cells were determined. Control mice were treated with vehicle only.

Quantitative Reverse Transcription PCR Assay for IL-12R mRNA Measurement.
-------------------------------------------------------------------------

C57BL/6, CD1d^−/−^, and Vα14 NKT cell--deficient mice were injected with α-GalCer (2 μg/mouse i.v.) or vehicle. At different time points (0--6 h) after treatment, mice were killed and spleen cells were isolated. TaqMan™ real-time quantitative reverse transcription (RT)-PCR assay was carried out for the detection of IL-12R mRNA expression by these cells according to published methods ([@B14]). In brief, total RNA extracts from the cells were added to the master mixture. To detect the amount of the IL-12R mRNA RT-PCR amplificon, target (IL-12Rβ1, IL-12Rβ2) and control (glyceraldehyde 3-phosphate dehydrogenase \[GAPDH\]) hybridization probes were mixed with target and control PCR primers, respectively. This mixture was transferred to a set of thermocycler tubes and transcribed at 42°C for 30 min, followed by 40 cycles of amplification at 95°C for 15 s and 60°C for 1.5 min, and analyzed using an ABI PRISM 7700 sequence detector (Applied Biosystems). IL-12Rβ1 and IL-12Rβ2 mRNA expression were estimated from the ratio of fluorescence intensity to GAPDH. IL-12R expression induced by α-GalCer is indicated in the figures as induction index, calculated as follows: induction index = IL-12R expression of α-GalCer--stimulated sample/IL-12R expression of unstimulated sample.

TaqMan™ probes used for these analyses are as follows: IL-12Rβ1 mRNA-605T, 5′-CGGATGCCCACAACGAATTGGA-3′; IL-12Rβ2 mRNA-551T, 5′-AGCCACCTCAAAACATATCATGTGTCCAGG-3′; GAPDH-542T, 5′-CCTGGCCAAGGTCATCCATGACAACTTT-3′.

PCR primers used for these analyses are as follows: IL-12β1 mRNA, forward primer (-563F) 5′-AATGTGTCTGAAGAGGCCGGT-3′ and reverse primer (-657R) 5′-GAGTTAACCTGAGGTCCGCAGT-3′; IL-12Rβ2 mRNA, forward primer (-529F) 5′-ATCTCAGTTGGTGTTGCTCCA-3′ and reverse primer (-602R) 5′-GCCACAGTTCCATTTTCTCCT-3′; GAPDH, forward primer (-368F) 5′-CTTCACCACCATGGAGAAGGC-3′ and reverse primer (-605R) 5′-GGCATGGACTGTGGTCATGAG-3′.

Blocking of IL-12R Induction by Anti--IFN-γ mAb.
------------------------------------------------

Wild-type C57BL/6 mice were injected with 500 μg i.p. anti--IFN-γ mAb (R4-6A2; PharMingen) or IL-12 (C15.1 and C15.6, donated by Dr. G. Trinchieri, Wistar Institute of Anatomy and Biology, Philadelphia, PA) at 0 and 1 d before priming with α-GalCer. As a control, the same amount of rat IgG1 (PharMingen) was injected intraperitoneally into control mice before injection of α-GalCer.

Results
=======

α-GalCer Selectively Activates NK1.1^+^TCR-α/β^+^ NKT Cells.
------------------------------------------------------------

To provide direct evidence that NKT cells are the only target cells for activation by α-GalCer, various lymphoid subsets were isolated from mouse spleen cell suspensions by flow cytometry and cocultured with DCs in the presence of α-GalCer. After 36 h of culture, the supernatants were harvested and their IL-4 and IFN-γ contents were measured by ELISA. Fig. [1](#F1){ref-type="fig"} shows that purified NK1.1^+^ T cells produce higher levels of IL-4 and IFN-γ than unfractionated spleen cells. The IFN-γ produced in these cultures was not derived from classical NK cells, because enrichment of NK1.1^+^TCR-α/β^−^ NK cells showed no significant cytokine production. In contrast, NK1.1^+^ TCR-α/β^+^ cells, which represent the NKT cell population, revealed markedly high levels of IL-4 and IFN-γ production. Although CD4^+^ T cells produced higher levels of cytokines compared with unfractionated spleen cells, this appeared to be due to the presence of CD4^+^NK1.1^+^ NKT cells, because CD4^+^NK1.1^−^ cells produced neither IL-4 nor IFN-γ in response to α-GalCer. Culture of NK1.1^+^ TCR-α/β^+^ NKT cells alone or with DCs in the absence of α-GalCer caused no significant production of IFN-γ or IL-4, indicating that DCs are essential for the stimulation of cytokine production by NKT cells.

Endogenous IL-12 Production by DCs Is Essential for the Triggering of NKT Cells.
--------------------------------------------------------------------------------

Fig. [2](#F2){ref-type="fig"} A shows that coculture of DCs and NKT cells in the presence of α-GalCer results in high levels of IFN-γ production. However, addition of anti--IL-12 mAb into these cultures caused a marked inhibition of IFN-γ production. Such inhibition was not observed when control anti-CD8 rat IgG mAb was added. Therefore, these results indicated that endogenously produced IL-12 by DCs was essential for the early activation of NKT cells by α-GalCer. The effect of mAbs against CD40 and CD40L on the activation of NKT cells by α-GalCer was also investigated (Fig. [2](#F2){ref-type="fig"} B). Both anti-CD40 mAb and anti-CD40L mAb greatly inhibited the production of IFN-γ by NKT cells in response to α-GalCer. These findings suggested that direct contact between DCs and NKT cells through CD40/CD40L interactions is critically important for the activation of NKT cells by α-GalCer. To study the requirements for IL-12 production by DCs in these cultures in further detail, IL-12 p70 activity in culture supernatants was measured by ELISA. As shown in Fig. [2](#F2){ref-type="fig"} C, DCs produced IL-12 p70 when cultured with NKT cells and α-GalCer. However, DCs did not produce IL-12 p70 when cultured with α-GalCer alone or when cultured with α-GalCer and NK (NK1.1^+^TCR-α/β^−^) cells.

α-GalCer Induces IL-12R Expression on NKT Cells.
------------------------------------------------

The effect of α-GalCer on the induction of IL-12R mRNA expression in spleen cells was examined by RT-PCR. As shown in Fig. [3](#F3){ref-type="fig"}, intravenous injection of α-GalCer into C57BL/6 mice caused the induction of mRNA for both IL-12Rβ1 and IL-12Rβ2 in spleen cells within 4 h. This upregulation of IL-12R was strongly blocked by administration of anti--IL-12 mAb or anti--IFN-γ mAb before injection of α-GalCer (Fig. [4](#F4){ref-type="fig"}). Moreover, the IL-12R induction by α-GalCer was almost completely abolished in both CD1d^−/−^ and Vα14 NKT cell--deficient mice (Fig. [5](#F5){ref-type="fig"}, A and B). Thus, these results suggested that CD1d-dependent α-GalCer--induced IFN-γ production by NKT cells may be critically important for the upregulation of IL-12R on NKT cells. To provide direct evidence for this hypothesis, we measured the expression of IL-12R on purified NKT cells that were previously activated in the presence of DCs and α-GalCer, either in vitro or in vivo. Fig. [5](#F5){ref-type="fig"} C shows that in vitro activation of spleen cells by DCs plus α-GalCer strongly induced the expression of IL-12R on NKT cells. Similar findings were made when mice were injected in vivo with α-GalCer (Fig. [5](#F5){ref-type="fig"} D).

α-GalCer Synergistically Acts with Exogenously Administered IL-12 in the Activation of Natural Killing Activity and IFN-γ Production In Vivo.
---------------------------------------------------------------------------------------------------------------------------------------------

C57BL/6 mice were injected intravenously with α-GalCer, and their splenic natural killing activity against YAC-1 cells was determined 24 h later. As shown in Fig. [6](#F6){ref-type="fig"} A, a suboptimal dose of neither α-GalCer nor IL-12 was able to activate natural killing activity in vivo. However, combined administration of α-GalCer and IL-12 at a suboptimal dose caused a marked augmentation of natural killing.

A similar synergistic effect of α-GalCer and IL-12 was demonstrated for the elevation of serum IFN-γ production. As shown in Fig. [6](#F6){ref-type="fig"} B, the administration of α-GalCer plus IL-12 resulted in a strong enhancement of serum IFN-γ levels in C57BL/6 mice compared with mice treated with α-GalCer or IL-12 only.

Discussion
==========

The finding that NKT cells recognize α-GalCer presented by DCs in a CD1d-dependent manner represents a novel recognition mechanism in the immune system ([@B15]). NKT cells, which can produce both IFN-γ and IL-4 ([@B16], [@B17]), play an important role in immunoregulation and have been considered to play a central role as innate effector cells involved in both the protection and the onset of immune diseases ([@B18]). The NKT cell ligand α-GalCer has a strong immunopotentiating effect in vivo, and this chemical mediates strong antitumor activity ([@B3]--[@B5], [@B9]). Therefore, it is important to dissect the mechanism by which α-GalCer activates NKT cells.

The previous finding ([@B3]) that NKT-deficient mice did not respond to α-GalCer strongly suggested that NKT cells may be the primary target cells to α-GalCer. However, it still remained unclear whether only NKT cells responded to α-GalCer. To answer this question, we used highly purified splenic NK cells, NKT cells, CD4^+^ T cells, and CD8^+^ T cells and determined their responsiveness to α-GalCer in the presence of DCs. The data illustrated in Fig. [1](#F1){ref-type="fig"} clearly demonstrate that NKT cells are the only cells that respond to α-GalCer ([@B3]). It is surprising that neither classical NK cells nor mainstream CD4^+^ T cells or CD8^+^ T cells revealed a significant response to α-GalCer even in the presence of DCs. Together with previous findings ([@B3]), the present data indicate that α-GalCer selectively stimulates NKT cells in the presence of DCs.

Recently, the mechanisms of activation of naive CD4^+^ T cells through interaction with DCs have been examined ([@B12], [@B19]--[@B22]). Cell--cell adhesion between CD4^+^ T cells and DCs through CD40/CD40L and B7.1/CD28 resulted in the activation of both DCs and T cells, which triggered the production of IL-12 by DCs and IFN-γ by Th1 cells ([@B12], [@B19], [@B20], [@B23]--[@B25]). Such conditioned DCs were able to prime cytotoxic T cells ([@B22], [@B26], [@B27]). This recognition system has resemblance to that discussed here. As shown in Fig. [2](#F2){ref-type="fig"}, IL-12 production by DCs appears to be essential for NKT cell activation by α-GalCer, because neutralization of endogenously produced IL-12 by anti--IL-12 mAb caused a strong inhibition of IFN-γ production by NKT cells. The important role of CD40/CD40L for the production of IFN-γ in the cocultures of DCs and NKT cells with α-GalCer is also apparent from these experiments (Fig. [2](#F2){ref-type="fig"} B). As demonstrated in Fig. [2](#F2){ref-type="fig"} C, DCs produce IL-12 only when they are cultured with α-GalCer in the presence of NKT cells, indicating that direct contact between α-GalCer--bound DCs and NKT cells may be essential for IL-12 production by DCs. This interaction may be required for the production of IFN-γ by IL-12--activated NKT cells, because mAbs directed against CD40/CD40L greatly inhibited IFN-γ production by NKT cells (Fig. [2](#F2){ref-type="fig"}). These findings indicate that the interaction of NKT cells with DCs may be very similar to the interaction of helper T cells with DCs ([@B22], [@B26], [@B27]). Since the interactions between DCs and NKT cells occur very quickly after administration of α-GalCer, NKT cells may be able to condition DCs very early in an immune response, and affect subsequent adaptive responses.

In this paper, we also demonstrate that α-GalCer upregulates IL-12R expression in vivo (Fig. [3](#F3){ref-type="fig"}). IL-12R upregulation is blocked by mAbs against IL-12 or IFN-γ and is absent in CD1d^−/−^ and NKT-deficient mice (Figs. [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). Moreover, activation of NKT cells in vitro and in vivo results in a strong induction of IL-12Rβ1 and IL-12Rβ2 on these cells (Fig. [5](#F5){ref-type="fig"}, C and D). Therefore, we speculate that the following series of events is induced upon culture of α-GalCer with DCs and NKT cells: (*a*) α-GalCer first binds to CD1d molecules on DCs; (*b*) NKT cells recognize α-GalCer--bound DCs via their TCRs and also interact with DCs via CD40/CD40L; (*c*) during this interaction, DCs produce IL-12; (*d*) the endogenously produced IL-12 stimulates IFN-γ production by NKT cells; and (*e*) IFN-γ produced by NKT cells upregulates IL-12R on NKT cells in an autocrine manner. The dramatic synergistic effect of suboptimal α-GalCer and exogenously administered IL-12 indicates that expression of IL-12Rβ1 and β2, detected by quantitative RT-PCR, is functionally upregulated in vivo. Moreover, since this synergistic effect of α-GalCer and IL-12 was not demonstrated in NKT-deficient mice, we conclude that in wild-type mice coadministration of α-GalCer and IL-12 leads to upregulation of IL-12R on CD1-dependent NKT cells.

Both α-GalCer and IL-12 have been demonstrated to exhibit potent antitumor activity in vivo. IL-12 has multiple effects on the immune system that are beneficial for the induction of antitumor immunity in vivo ([@B28]--[@B30]). However, the unexpected severe side effects of IL-12 have made it difficult to use this cytokine in clinical trials ([@B31]). We demonstrated that α-GalCer synergistically acts with small doses of IL-12 in vivo to activate NKT cells and to induce IFN-γ production (Fig. [6](#F6){ref-type="fig"}). These findings suggest that coadministration of α-GalCer with IL-12 could be used as a new approach for tumor immunotherapy.

Recent studies have demonstrated that Th1 immunity regulated by IL-12 and IFN-γ plays a critical role in the induction of protective immunity against tumors and infectious agents ([@B32], [@B33]). Although NKT cells are involved in both Th1 and Th2 immunity through IFN-γ or IL-4 production, the immunomodulating protocol using α-GalCer and IL-12 preferentially induces NKT cells that produce large amounts of IFN-γ ([@B34]). These NKT cells may facilitate the development of Th1-dominant cellular immunity essential for the induction of protective immunity against tumors and some infectious agents. Recently, it was demonstrated that α-GalCer can stimulate human NKT cells in a CD1d-dependent manner ([@B35], [@B36]), indicating that our proposed immunotherapy protocol using α-GalCer and IL-12 will be useful for the application to human immune diseases, including cancer.
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![α-GalCer selectively activates NK1.1^+^TCR-α/β^+^ NKT cells. Spleen cells from C57BL/6 mice were separated into a variety of lymphoid cell subsets by cell sorting as described in Materials and Methods. Their responsiveness to α-GalCer in the presence of DCs was then determined by measuring IL-4 (▪) and IFN-γ () levels in the culture supernatants using ELISA. As a control, NK1.1^+^TCR-α/β^+^ NKT cells were cultured alone or with DCs in the absence of α-GalCer. The bars represent mean ± SE of triplicate samples.](JEM981976.f1){#F1}

![Endogenously produced IL-12 and CD40/CD40L interaction during coculture of DCs and NKT cells is essential for NKT cell activation by α-GalCer. Purified NKT cells were cocultured with DCs in the presence of α-GalCer for 36 h. The IFN-γ levels in culture supernatants were then determined by ELISA. (A) The ability of anti--IL-12 mAb to block NKT cell activation by α-GalCer. Anti-CD8 mAb was used as control rat IgG Ab. (B) The ability of anti-CD40 mAb and anti-CD40L mAb to block NKT cell activation by α-GalCer. As a control, rat anti-CD8 IgG mAb was added to the culture. (C) IL-12 production by DCs cultured with α-GalCer and NKT cells. DCs (5 × 10^5^) were activated with 50 ng/ml of α-GalCer for 8 h in the presence or absence of NK1.1^+^TCR-α/β^−^ NK cells (10^5^) or NK1.1^+^TCR-α/β^+^ NKT cells (10^5^). The bars represent mean ± SE of triplicate samples.](JEM981976.f2){#F2}

![Upregulation of IL-12R expression in the spleen upon in vivo administration of α-GalCer. C57BL/6 mice were injected intravenously with α-GalCer. Various times (0, 2, 4, and 6 h) after the treatment, spleen cells were prepared and their expression of IL-12Rβ1 (•) and IL-12Rβ2 (○) mRNA was measured by quantitative RT-PCR. The IL-12R mRNA levels are represented as an induction index, as described in Materials and Methods. The bars represent mean ± SE of triplicate samples.](JEM981976.f3){#F3}

![Role of IL-12 and IFN-γ in the induction of IL-12R expression in the spleen. C57BL/6 mice were injected intravenously with α-GalCer. 4 h after the injection, spleen cells were prepared and their expression of IL-12Rβ1 () and IL-12Rβ2 (▪) mRNA was measured by quantitative RT-PCR. The IL-12R mRNA levels are presented as an induction index, as described in Materials and Methods. The blocking effect of anti--IL-12 mAb and anti--IFN-γ mAb was determined by injection of these mAbs (500 μg/mouse i.p.) into the mice 1 and 0 d before the treatment with α-GalCer. The bars represent mean ± SE of triplicate samples.](JEM981976.f4){#F4}

![α-GalCer induces IL-12R expression on NKT cells. C57BL/6 wild-type mice, CD1d^−/−^ mice, and NKT-deficient mice were injected intravenously with vehicle () or α-GalCer (▪). 4 h after the injection, spleen cells were prepared and their expression of IL-12Rβ1 (A) and IL-12Rβ2 (B) mRNA was measured by quantitative RT-PCR. (C) Spleen cells from wild-type mice were cultured with DCs plus α-GalCer or vehicle for 8 h, NK1.1^+^TCR-α/β^+^ NKT cells were purified by cell sorting, and the expression of IL-12Rβ1 () and IL-12Rβ2 (▪) was examined by quantitative RT-PCR. (D) Wild-type mice were injected intravenously with α-GalCer or vehicle; after 6 h the spleens from these mice were isolated, and NK1.1^+^TCR-α/β^+^ NKT cells were purified by cell sorting, and expression of IL-12Rβ1 () and IL-12Rβ2 (▪) was examined by quantitative RT-PCR. The IL-12R mRNA levels are presented as an induction index, as described in Materials and Methods. The bars represent mean ± SE of triplicate samples.](JEM981976.f5){#F5}

![Synergistic effect of α-GalCer and IL-12 in vivo. C57BL/6 mice were injected with a suboptimal dose of α-GalCer (200 ng/mouse i.v.) and 6 h later, mice were injected with a suboptimal dose of IL-12 (200 U/mouse i.p.). 1 d after the treatment with IL-12, the mice were killed and splenic natural killing activity (A) and serum IFN-γ levels (B) were determined as described in Materials and Methods. The bars represent mean ± SE of triplicate samples.](JEM981976.f6){#F6}
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